Global emergence and γ-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam - Poll - MDSpire

Global emergence and γ-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam

  • By

  • Caitlyn Norman

  • Dean Acreman

  • Meera Bissram

  • Blake Curtis

  • Sebastian Hamer

  • Folker Westphal

  • Michael Putz

  • Cristiana Stefan

  • Sarah R. Delaney

  • Rick Lines

  • Malcolm D. McLeod

  • Karen McDonald

  • Henrik Green

  • May 20, 2026

  • 0 min

Share

Original Source(s)

Global emergence and γ-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam

  • by Caitlyn Norman, Dean Acreman, Meera Bissram, Blake Curtis, Sebastian Hamer, Folker Westphal, Michael Putz, Cristiana Stefan, Sarah R. Delaney, Rick Lines, Malcolm D. McLeod, Karen McDonald, Henrik Green

  • May 20, 2026

Related Content

FaReWell Depression – a randomized controlled trial of a physiotherapeutic program for the facial rehabilitation of wellbeing in depression

Virtual Reality Interventions for Stress Reduction in the General Population: Systematic Review and Meta-Analysis of Randomized Controlled Trials

The dual-sensitive period gut-brain crosstalk, neuroinflammation, and the biological roots of adolescent depression